Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,120
-490 (-2.63%)
Mar 3, 2026, 12:00 PM KST
29.15%
Market Cap 639.64B
Revenue (ttm) 231.90B
Net Income (ttm) -3.71B
Shares Out n/a
EPS (ttm) -74.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,111
Average Volume 3,879
Open 18,200
Previous Close 18,610
Day's Range 18,120 - 18,200
52-Week Range 9,650 - 55,000
Beta 1.35
RSI 33.45
Earnings Date Mar 20, 2026

About KRX:019175

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 809
Stock Exchange Korea Stock Exchange
Ticker Symbol 019175
Full Company Profile

Financial Performance

In 2024, KRX:019175's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements

News

There is no news available yet.